Summary Information:
Enlivex Therapeutics Ltd. Ordinary Shares
NASDAQ:ENLV
email
admin@troach.net 		Our Main Pages
Stocks.TRoach.Net
TRoach.Org
TRoach.Net
NOTE: This page is for evaluation of a JFF Project.
This page is NOT updated on a regular basis.
Information on this page should NOT be used for investment purposes.
Enlivex Therapeutics Ltd. Ordinary Shares
Exchange: NASDAQ
Symbol: ENLV
SEC CIK: 0001596812
Phone: 972 (0) 3 7326616
37 DEREH MENACHEM BEGIN ST.
15TH FLOOR
TEL AVIV L3 6522042
CEO: Oren Hershkovitz
Price Quote by TradingView
Price when page updated: 1.8773 Date: 2023-11-30
Company Website:
www.enlivex.com

_Description: Enlivex is a clinical stage immunotherapy company developing AllocetraTM, a universal, off-the-shelf cell therapy designed to reprogram macrophages into their homeostatic state. Resetting non-homeostatic macrophages into their homeostatic state is critical for immune system rebalancing and resolution of life-threatening conditions.

IPO YEAR:
2014
 Sector:
Health Care
 Industry:
Biotechnology: Pharmaceutical Preparations
ADRTSO:

MarketCap:
34579866.00
 Beta:
1.273955116072921
52 Week High:
29.4
 52 Week Low:
5.86
 52 Week Change:
-0.4061302681992337
Short Interest:

Short Date:

Shares Outstanding:
18310507
Dividend Rate:
0
 Dividend Yield:
N/A
ExDividend Date:

Latest EPS:

Latest EPS Date:
N/A
Float:
0
return on Equity:
-22.90%
 Consensus EPS:

Number Of Estimates:
EPS Surprise Dollar:

Eps Surprise Percent:

EBITDA:
-$21.27
ttmEPS:
0
 Revenue:
N/A
 Gross Profit:
Cash:

Debt:

Institution Percent:
11.70%
Revenue Percent:

Revenue Per Employee:

Insider Percent:
12.22%
Return on Assets:
-20.70%
 Return on Capital:

Profit Margin:
-
Price to Sales:
-
 Price To Book:
1.20
 Short Ratio:
4.70
PE Ratio:
0
 Employees:
50
 1Y Guesstimate
11.505:2.0:6


__The following are links to various summary and news pages for
__Enlivex Therapeutics Ltd. Ordinary Shares [ ENLV ].

__Note: Some Links might not have information for the company.


finance.Yahoo.com money.CNN.com NASDAQ research
WalletInvestor.com WSJ.com MarketBeat.com
finviz.com WallMine.com TheGlobeandMail.com
stock1010.com
NASDAQ - General Info SEC Insider Report Ownership Summary
Dividend History insiderbuyingselling.com
Facebook search Twitter search LinkedIn search
PRnewsWire.Com Google Forecast
tdameritrade.com BarChart.com
SeekingAlpha.com Markets.FT.com stocktwits.com
FinTel.io Ldmicro.com bloomberg.com
MarketWatch.com Reuters.com businessinsider.com
fool.com barrons.com zacks.com
GuruFocus.com Investing.com tipranks.com
thestreet.com nytimes.com earningswhispers.com
marketchameleon.com sunshineavenue.com stockinvest.us
stockanalysis.com stockconsultant.com ycharts.com
financialcontent.com docoh.com foxbusiness.com
cnbc.com investorsobserver.com tradingview.com
investopedia.com tmxmoney.com invest.cnyes.com
ask.com bing.com brave.com
duckduckgo.com ecosia.org excite.com
exalead.com gibiru.com hotbot.com
www.info.com infospace.com lycos.com
lukol.com metacrawler.com mojeek.com
becovi.com searx.thegpm.org search.com
swisscows.com webcrawler.com yahoo.com
yandex.com yep.com you.com




INDEX



Page design by: TRoach
Page Last Updated: 2023-11-30